These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29199496)

  • 1. Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment.
    Pisanu C; Katsila T; Patrinos GP; Squassina A
    Pharmacogenomics; 2018 Jan; 19(2):129-143. PubMed ID: 29199496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: Potential involvement of epigenetics.
    Pisanu C; Papadima EM; Del Zompo M; Squassina A
    Neurosci Lett; 2018 Mar; 669():24-31. PubMed ID: 27343410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics in bipolar disorder: a critical review of the literature.
    Legrand A; Iftimovici A; Khayachi A; Chaumette B
    Psychiatr Genet; 2021 Feb; 31(1):1-12. PubMed ID: 33290382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.
    Pisanu C; Heilbronner U; Squassina A
    Mol Diagn Ther; 2018 Aug; 22(4):409-420. PubMed ID: 29790107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mood stabilizers on DNA methylation in human neuroblastoma cells.
    Asai T; Bundo M; Sugawara H; Sunaga F; Ueda J; Tanaka G; Ishigooka J; Kasai K; Kato T; Iwamoto K
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2285-94. PubMed ID: 23931339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium Pharmacogenetics: Where Do We Stand?
    Pisanu C; Melis C; Squassina A
    Drug Dev Res; 2016 Nov; 77(7):368-373. PubMed ID: 27633500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
    J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting bipolar disorder complexity through epigenomic approach.
    Ludwig B; Dwivedi Y
    Mol Psychiatry; 2016 Nov; 21(11):1490-1498. PubMed ID: 27480490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopment and mood stabilizers.
    Harwood AJ
    Curr Mol Med; 2003 Aug; 3(5):472-82. PubMed ID: 12943000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Drugs for Mood Disorders.
    Peedicayil J; Kumar A
    Prog Mol Biol Transl Sci; 2018; 157():151-174. PubMed ID: 29933949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-myo-inositol co-transporter (SMIT-1) mRNA is increased in neutrophils of patients with bipolar 1 disorder and down-regulated under treatment with mood stabilizers.
    Willmroth F; Drieling T; Lamla U; Marcushen M; Wark HJ; van Calker D
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):63-71. PubMed ID: 16420717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood stabilizers for patients with bipolar disorder: the state of the art.
    Altamura AC; Lietti L; Dobrea C; Benatti B; Arici C; Dell'Osso B
    Expert Rev Neurother; 2011 Jan; 11(1):85-99. PubMed ID: 21158558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs.
    Tardito D; Mallei A; Popoli M
    Expert Opin Investig Drugs; 2013 Feb; 22(2):217-33. PubMed ID: 23253113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder.
    Houtepen LC; van Bergen AH; Vinkers CH; Boks MP
    Epigenomics; 2016 Feb; 8(2):197-208. PubMed ID: 26792232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance therapies in bipolar disorder: focus on randomized controlled trials.
    Muzina DJ; Calabrese JR
    Aust N Z J Psychiatry; 2005 Aug; 39(8):652-61. PubMed ID: 16050919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA and epigenomics.
    Kanduri C
    Adv Exp Med Biol; 2011; 722():174-95. PubMed ID: 21915789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between mood stabilizers and hypothyroidism in patients with bipolar disorders: a nested, matched case-control study.
    Gau CS; Chang CJ; Tsai FJ; Chao PF; Gau SS
    Bipolar Disord; 2010 May; 12(3):253-63. PubMed ID: 20565432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and maintenance treatment with mood stabilizers.
    Bowden CL
    Int J Neuropsychopharmacol; 2003 Sep; 6(3):269-75. PubMed ID: 12974993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mini review: Recent advances on epigenetic effects of lithium.
    Marie-Claire C; Etain B; Bellivier F
    Neurosci Lett; 2021 Sep; 761():136116. PubMed ID: 34274436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.